small molecule

DICLOFENAC SODIUM AND MISOPROSTOL

DICLOFENAC SODIUM; MISOPROSTOL

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameDICLOFENAC SODIUM AND MISOPROSTOL
Active ingredientDICLOFENAC SODIUM; MISOPROSTOL
Strength75MG;0.2MG
Dosage formTABLET, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2016
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.